Jesus D. Anampa, MD, MS, discussed SEER database trends in chemotherapy use for older women with TBNC and explained the rationale for using breast cancer–free survival vs OS.
Jesus D. Anampa, MD, MS
Advertisement
Articles by Jesus D. Anampa, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
VT-EBV-N Yields Durable Disease-Free Survival in Pretreated ENKTL
2
Tisa-Cel Yields Enduring Remissions in Younger High-Risk B-ALL Population
3
Anbenitamab Regimen Meets Phase 3 End Points in HER2+ Breast Cancer
4
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
5